Cross Country Healthcare, Inc. (NASDAQ:CCRN) CAO Christopher R. Pizzi sold 8,379 shares of the business’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $12.45, for a total value of $104,318.55. Following the completion of the transaction, the chief accounting officer now owns 42,131 shares of the company’s stock, valued at $524,530.95. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Shares of NASDAQ CCRN traded down $0.02 during trading on Wednesday, hitting $12.48. 1,404 shares of the company traded hands, compared to its average volume of 197,749. Cross Country Healthcare, Inc. has a 1 year low of $6.75 and a 1 year high of $12.99. The company has a 50-day moving average price of $10.64 and a 200-day moving average price of $9.33. The firm has a market capitalization of $466.86 million, a P/E ratio of 104.00, a P/E/G ratio of 10.43 and a beta of 1.28. The company has a quick ratio of 2.03, a current ratio of 2.03 and a debt-to-equity ratio of 0.55.
Cross Country Healthcare (NASDAQ:CCRN) last announced its quarterly earnings data on Tuesday, November 5th. The business services provider reported $0.05 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.01 by $0.04. Cross Country Healthcare had a negative net margin of 9.44% and a positive return on equity of 1.30%. The company had revenue of $209.20 million during the quarter, compared to analysts’ expectations of $202.60 million. During the same period in the previous year, the company earned $0.02 EPS. The business’s quarterly revenue was up 4.2% compared to the same quarter last year. Research analysts predict that Cross Country Healthcare, Inc. will post 0.12 EPS for the current fiscal year.
CCRN has been the subject of several analyst reports. BMO Capital Markets boosted their price target on Cross Country Healthcare from $10.00 to $12.00 and gave the company a “market perform” rating in a report on Wednesday, November 6th. Zacks Investment Research upgraded Cross Country Healthcare from a “hold” rating to a “strong-buy” rating and set a $12.00 price target for the company in a report on Tuesday, October 1st. BidaskClub raised shares of Cross Country Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, November 8th. Finally, ValuEngine cut shares of Cross Country Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Three investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. Cross Country Healthcare presently has a consensus rating of “Buy” and an average target price of $11.33.
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments.
Recommended Story: Street Name
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.